Serum level of visfatin can reflect the severity of inflammation in patients with acute cholecystitis.
Jae Woo ParkOk-Hee KimSang Chul LeeKee-Hwan KimHa-Eun HongHaeyeon SeoHo Joong ChoiSay June KimPublished in: Annals of surgical treatment and research (2020)
Taken together, we concluded that visfatin is a pro-inflammatory mediators that is upregulated during acute cholecystitis and is expected to be increased within a short time after inflammation. Therefore, measuring the serum level of visfatin would be helpful in predicting the inflammatory severity in the patients with acute cholecystitis.